FEIBA NF DIN 02489600
Status: Approved
Holder: TAKEDA CANADA INC
Health Canada record
| Active ingredient(s) | ANTI-INHIBITOR COAGULANT COMPLEX 650 UNIT |
|---|
| Dosage form | Powder For Solution; Kit |
|---|
| Route | Intravenous |
|---|
| Schedule | SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | B02BD03 FACTOR VIII INHIBITOR BYPASSING ACTIVITY |
|---|
| Original market date | |
|---|
| Current status date | 29-Dec-2020 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Takeda Canada Inc. — licence 101769, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ANTI-INHIBITOR COAGULANT COMPLEX
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02202581 | FEIBA NF | TAKEDA CANADA INC | Kit; Powder For Solution | ANTI-INHIBITOR COAGULANT COMPLEX 1300 UNIT | Marketed |
| 02353903 | FEIBA NF | TAKEDA CANADA INC | Kit; Powder For Solution | ANTI-INHIBITOR COAGULANT COMPLEX 3250 UNIT | Marketed |
| 02480549 | FEIBA NF | TAKEDA CANADA INC | Kit; Powder For Solution | ANTI-INHIBITOR COAGULANT COMPLEX 650 UNIT | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 24900 | 2020-09-29 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER. LABELLING UPDATES |
| 22296 | 2019-06-18 | Supplement to a New Drug Submission (SNDS) | New strength |
Request a quote for FEIBA NF
How to read a Canadian DIN record